| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.68▼ | 1.69▼ | 1.69▼ | 1.68▼ | 1.67▲ |
| MA10 | 1.69▼ | 1.69▼ | 1.69▼ | 1.66▲ | 1.70▼ |
| MA20 | 1.69▼ | 1.70▼ | 1.69▼ | 1.66▲ | 1.75▼ |
| MA50 | 1.68▼ | 1.67▲ | 1.66▲ | 1.70▼ | 1.84▼ |
| MA100 | 1.66▲ | 1.67▲ | 1.68▼ | 1.75▼ | 2.09▼ |
| MA200 | 1.68▼ | 1.70▼ | 1.70▼ | 1.82▼ | 2.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | -0.003▼ | 0.006▲ | 0.003▲ |
| RSI | 40.995▼ | 45.885▼ | 47.820▼ | 49.091▼ | 45.521▼ |
| STOCH | 16.667▼ | 20.000 | 16.863▼ | 47.976 | 34.552 |
| WILL %R | -100.000▼ | -100.000▼ | -76.471▼ | -52.941 | -55.032 |
| CCI | -175.402▼ | -189.412▼ | -91.685 | 56.632 | 15.990 |
|
Thursday, September 11, 2025 07:18 AM
Immutep (ASX:IMM, NASDAQ:IMMP) is developing late-stage immunotherapies for cancer and autoimmune disease centred on the LAG-3 protein. Marc Voigt, CEO, says the company is leveraging its diversified ...
|
|
Monday, September 08, 2025 05:12 AM
Data to be presented in the Immunotherapy & Cell Therapy in Sarcoma: Emerging Frontiers session at the Connective Tissue Oncology Society (CTOS) 2025 Annual Meeting SYDNEY, AUSTRALIA, Sept. 08, 2025 ...
|
|
Sunday, September 07, 2025 05:48 AM
Immutep Limited (ASX:IMM; NASDAQ:IMMP) will present new data from its Phase II EFTISARC-NEO trial at the Connective Tissue Oncology Society (CTOS) 2025 Annual Meeting in Boca Raton, Florida. The study ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/09/25 | 1.68 | 1.7061 | 1.67 | 1.67 | 33,168 |
| 16/09/25 | 1.69 | 1.72 | 1.68 | 1.69 | 53,060 |
| 15/09/25 | 1.71 | 1.76 | 1.71 | 1.73 | 94,415 |
| 12/09/25 | 1.67 | 1.67 | 1.63 | 1.64 | 32,751 |
| 11/09/25 | 1.67 | 1.68 | 1.60 | 1.66 | 92,991 |
| 10/09/25 | 1.61 | 1.67 | 1.61 | 1.63 | 64,387 |
| 09/09/25 | 1.70 | 1.71 | 1.60 | 1.60 | 137,606 |
| 08/09/25 | 1.65 | 1.75 | 1.65 | 1.72 | 123,084 |
| 05/09/25 | 1.64 | 1.67 | 1.5912 | 1.65 | 182,871 |
| 04/09/25 | 1.66 | 1.67 | 1.59 | 1.62 | 143,875 |
|
|
||||
|
|
||||
|
|